Entropy rising within normal hematopoiesis is the core idea of the proposed thermodynamical model of malignancy in leukemia. Mathematically its description is supposed to be similar to the Lorenz system of ordinary differential equations for simplified processes of heat flow in fluids. The model provides description of remission and relapse in leukemia as two hierarchical and qualitatively different states of normal hematopoiesis with their own phase spaces. Phase space transition is possible through pitchfork bifurcation, which is considered as the common symmetrical scenario for relapse, induced remission and spontaneous remission of leukemia. Cytopenia is regarded as an adaptive reaction of hematopoiesis to entropy increase caused by leukemia clone. The following hypotheses are formulated: a) Percentage of leukemia cells in marrow as criterion of remission or relapse is not necessarily constant but a variable value; b) Probability of getting remission depends upon normal hematopoiesis reaching bifurcation; c) Duration of remission depends upon eradication of leukemia cells in induction or consolidation therapies; d) Excessively high doses of chemotherapy in consolidation might induce relapse.
and what to expect from it? Thermodynamics explains why something happens but does not show how it happens. It does not provide description of molecular mechanisms behind relapse or remission of leukemia, however it explains why spontaneous processes in leukemia are possible. Thermodynamics provides more accurate description of nonlinear aspect of leukemia dynamics than computational models of proliferating leukemia clone.
Mathematical description of entropy rising within normal hematopoiesis in leukemia is probably similar to entropy rising in heating shallow layer of fluid, known as Lorenz system. The role of leukemia clone in this context appears to be only a passive "heat" source while induced remission, spontaneous remission and relapse are considered as common manifestations of the same process of phase space transition through bifurcation in normal hematopoiesis.
The biggest weakness of this model is presentation of remission and relapse as two qualitatively different states of hematopoiesis in leukemia. The lack of experimental evidence for molecular mechanisms specific for remission or relapse can leave this model unsubstantiated. In addition, the model cannot be applied easily to analysis of solid cancers since the modelling conditions are different.
Thermodynamics provides a powerful tool for modelling different aspects of leukemia and thus it seems possible to build several thermodynamical models as alternatives to traditional linear model of leukemic clone expansion. Non-equilibrium aspect of leukemia might be modelled as a two-component unbalanced system of normal hematopoiesis and leukemic clone making a biological oscillator with entropy flow between its parts. A hybrid model of leukemia as a process of entropy rising within normal hematopoiesis and an upper level model of leukemia as a biological oscillator might be a next step in our modelling efforts.
Introduction.

Leukemia as a disease. Leukemia is a group of cancers involving blood cells of bone marrow.
Leukemia is the 11 th most common cancer worldwide, with around 352,000 new cases diagnosed in 2012 [13] . Malignant transformation usually occurs at the level of a pluripotent stem cell or committed progenitor cells with more limited capacity for differentiation. It is generally accepted, that abnormally high proliferation rate and longevity lead to expansion of leukemic clone in bone marrow and often into various other organs and sites, such as liver, spleen, lymph nodes, central nervous system, kidneys and gonads. Resulting disruption of hematopoiesis cause anemia, infection, easy bruising or bleeding.
In a typical case of acute leukemia such symptoms have usually been present for only days to weeks before diagnosis. Approximately 10 12 leukemia cell have been estimated to be present by that time [47] which indicates that the growing leukemic clone coexisted with normal hematopoiesis for months without any apparent signs of its presence.
New mutations in leukemic clone as a basis of leukemia progression. Relatively recent experimental
evidence suggests that acute myeloid leukemia may originate from multiple clones of malignant cells [9] . For chronic lymphocytic leukemia certain genetic events are found in the majority of cells which are considered as 'clonal driver mutations', whereas others, present only in a fraction of the tumor, are deemed to be 'subclonal driver mutations' [43] . Sequencing studies revealed about 140 genes that when altered by intragenic mutations can act as driver mutations during tumorigenesis [46] . The presence of sub-clonal driver mutations was associated with reduced survival in chronic lymphocytic leukemia [24] , and it seems that the degree of subclonality might serve as a cancer marker per se. Higher diversity is related to a higher mutation rate or longer tumor evolution with more replications [41] .
Possible mechanisms of normal hematopoiesis disruption in leukemia.
Interaction between the healthy and cancer cell lines is often described through a competition for physical space resulting in an increased cellular degradation. This is consistent with the observation of an increase of markers for cell death such as lactate dehydrogenase [3, 11, 22, 42] . Several mechanisms underlying this spatial competition have been proposed: overcrowding which results in extinction of cells [17] ; competition for a limited surface niche expressing certain receptors [4, 48] ; and apoptosis if no contacts to these receptors can be established [15] . Other possible mechanisms include induction of cytopenia by impeding hematopoietic stem cells proliferation and differentiation [26] and competition for energy and nutrients [39] . Although molecular mechanisms of disruption are not known, at the level of cell populations hematopoiesis disruption is consistent with competitive exclusion principle (also known under several other names including Volterra-Lotka Law), which postulates that populations competing for the same limiting resource in one homogeneous habitat cannot coexist long enough [18, 21] . However, it is still debatable whether competitive exclusion principle developed for ecosystems can be applied for processes at cellular level.
Clinical remission and relapse as two states of hematopoiesis in leukemia.
The first manifestation of leukemia means not only expansion of leukemia clone into marrow and other organs but also disruption of normal hematopoiesis leading to severe complications of the disease. The goal of induction therapy of leukemia is attainment of a complete remission, which usually requires a period of marrow aplasia, or a "morphologic leukemia-free state," following induction chemotherapy [47] .
Complete remission is currently defined as restoration of normal hematopoiesis with a blast cell fraction of less than 5% by light microscopic examination of the bone marrow. This relatively liberal definition reflects the difficulty of identifying leukemic blasts in regenerating marrow by morphologic criteria alone. Thus, patients with nearly 5% leukemic blast cells in their marrow specimens can harbor as many as 10 10 leukemia cells [5, 37] . Recurrence of leukemia, called relapse, after therapy is a common problem of leukemia. The goal of post-remission or consolidation therapy is to prolong complete remission by delaying or preventing relapse and to maximize the chance of cure [47] . In a typical acute leukemia with chemotherapy the leukemic process is staged strictly as relapse or remission while correlations between the kinetic parameters of the normal and leukemic populations are suggested to characterize the leukemic state [10] .
Spontaneous remission of leukemia.
Remission of leukemia without any specific therapy, called spontaneous remission, is an extremely rare and exceptional, relatively well documented but poorly understood phenomenon. Spontaneous remission of acute myeloid leukemia is almost always transient event, with a mean duration in the literature of 7.7 months (range 1-36) [14] . In a typical case of spontaneous remission the full restoration of normal hematopoiesis and disappearance of blast cells occur in patient with acute leukemia and concurrent infection [2, 7, 12, 16, 23, 27, 31, 32, 33, 36, 45] , blood transfusion [2, 14, 25, 36, 38] or cytokine injection [19, 44] . The underlying molecular mechanisms of spontaneous remission are still unknown. A potential role of bacterial or fungal infections and blood transfusions was suggested in spontaneous remission occurrence by triggering antileukemic and immune responses [35] . Activation of cytotoxic T lymphocytes and macrophages in conjunction with an increased cytotoxicity of Natural Killer cells as well as cytokines of the immune system such as tumor necrosis factor, interferon gamma, and interleukin-2, released during infection may play a role in the occurrence of spontaneous remission [6, 20, 29, 30, 31] . However, no clear link between spontaneous remission and infection or immune response was reported in at least one case [8] . In another report spontaneous remission was detected after termination of pregnancy [27] .
Lorenz system
Dynamical biological or physical systems display a variety of linear and nonlinear behaviors that can be described by corresponding mathematical models. Despite the diverse nature of processes, resulting mathematical description is quite similar, so it seems possible to understand some aspects of leukemia dynamics with the help of other models. This possibility of common mathematical description will be used to highlight similarities between leukemia and heat distribution in fluid flows.
Since leukemia increases entropy of normal hematopoiesis, Lorenz system is suggested to be used for modelling as it reflects a similar process of entropy rising in a uniformly heated and cooled shallow layer of fluid. Edward Norton Lorenz modeled weather and motion of air as it is heated and found that while being severely truncated version of Navier-Stokes equations (which arise from applying Newton's second law to viscous fluid motion), the system still preserves many of its characteristics. Detailed analysis of the Lorenz equations is out of scope of this article, however it is readily available and is commonly used as a simplified model of nonlinear system. Some terms of the theory of dynamical systems are used here when necessary in context of leukemia modelling. An introduction to the theory of dynamical systems is available [40] .
In brief, Lorenz model for convection is the system of three ordinary differential equations (1),(2),(3):
Given P=10 Lorenz found that the system behaves chaotically for R>24.74 when it starts with a rotation around one of the focuses with an amplitude increasing with time, thereby forming a divergent spiral. After a number of such oscillations, the system suddenly goes toward the second available focus through a bifurcation and it continues an oscillatory motion around the second available focus along a divergent spiral. After a certain number of oscillations around this focus, the system jumps back to the vicinity of the previous focus, from which it again begins a new divergent oscillatory trajectory (diagram 4) (based on [34] ).
Diagrams 1-4. Lorenz attractor. From initial steady state (diagram 1) the system compartmentalizes (diagrams 2 and 3) making two new steady states and pitchfork bifurcation. With subsequent entropy increase the system loses stability (diagram 4).
Discussion
Leukemia is an incarnation of chaos. The chaos begins from one or several mutations in cell genome All four hypotheses can be tested in laboratory and by statistical analysis, however refinement of the model appears to be more difficult. Presumably, it should include integration of both computational and dynamic aspects of leukemia clone and normal hematopoiesis interaction by a model of leukemia as a biological oscillator in terms of non-equilibrium thermodynamics. The model verification would also require development of methods for entropy assessment in cell populations on laboratory models and in humans.
Regulatory role of thermodynamic potential on cellular processes was not largely discussed. It is known that at the cellular level high temperatures and some external shock factors upregulate expression of Heat Shock Proteins, -chaperons with mainly stabilizing and protective role within cells.
Those changes might be also a part of regulatory effects of entropy fluctuations on normal hematopoiesis in leukemia, however, effects of weak thermodynamic temperature on cells and cell populations are still not proven.
Most existing models describe leukemia as linear process of tumor expansion in bone marrow.
Resulting failure of normal haematopoietic lineages is regarded as complication of leukemia. Presented thermodynamical model considers leukemia as a non-linear process of entropy rising within normal haematopoiesis caused by leukemia clone. Mathematical description of these events is similar to Lorenz system of differential equations for heat flow in fluids and thus the following metaphoric conclusion seems appropriate: "Leukemia is fire in blood".
